MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • 2017 International Congress

    Neuroticism and depression is associated with impulse control disorder in Parkinson’s disease: a controlled study

    N. Titova, N. Sotnikova, E. Katunina (Moscow, Russian Federation)

    Objective: Cross-sectional assessment of personality trait, impulsivity, depression and anxiety collected prospectively in Parkinson’s disease (PD) with impulse control disorders (PD-ICD) compared to a matched…
  • 2017 International Congress

    Efficacy of Tozadenant in Animal Models of Non-Motor Symptoms of Parkinson’s Disease

    C. Kostrub, C. Kenney, C. Riemer, E. Prinssen, A. Flohr, J.-L. Moreau (Ardsley, NY, USA)

    Objective: Investigate the potential of tozadenant (TOZ) to alleviate the non-motor symptoms of Parkinson's disease using multiple animal models. Background: TOZ is an oral, selective…
  • 2017 International Congress

    Consideration of the relationship between severity of Parkinson’s disease and cognitive function, depression, quality of life

    M. Saruwatari, M. Sagawa, A. Kumon, K. Hasegawa (Sagamihara, Japan)

    Objective: In this study, we aimed to clarify the relationship between PD severity and cognitive function, depression and quality of life. Background: We are continuing…
  • 2017 International Congress

    Parkinson’s Disease and Urogenital Dysfunction

    N. Sözer, M. Yenice, H. Erdogan, E. Demir, I. Yiğitbaşı, V. Tuğcu, V. Yayla (Istanbul, Turkey)

    Objective: The aim of this study is to identify  the involvement of urogenital functions in PD.  Background: Urogenital dysfunction could occur  in neurological diseases due to central…
  • 2017 International Congress

    Depression and Cognitive Performance in Patients with Parkinson’s Disease

    A.J. Jacob, S. OJ, S. K, G. Kumarpillai (Bangalore, India)

    Objective: The aim of this study was to assess the relationship between  depression on cognitive performance in Parkinson’s disease  patients.  Background: There are very few…
  • 2017 International Congress

    Association of pain and depression with Parkinson’s disease-osteoarthritis comorbidity.

    A.Q. Rana, A.R. Qureshi, Z. Sarfaraz, R. Rana (Toronto, ON, Canada)

    Objective: The goal of this study was to observe if additional pain associated with comorbid symptomatic OA in PD patients is correlated with greater depression…
  • 2017 International Congress

    Behavioral and psychological symptoms in Parkinson’s disease with SWEDDs

    J. Ahn, H. Kim (Seoul, Republic of Korea)

    Objective: To assess behavioral and psychological symptoms in patients of Parkinson's disease with SWEDDs(PD-SWEDDs.. Background: Behavioral and psychological symptoms are often seen in patients with…
  • 2017 International Congress

    Vmat2 heterozygote mice display motor dysfunction and progressive depressive-like behaviors

    K. Ma, J. Huang, L. Liu, C. Han, X. Guo, S. Guo, L. Wang, Y. Shen, Y. Xia, F. Wan, N. Xiong, T. Wang (Wuhan, China)

    Objective: To assess motor and depressive behaviors in mice that are heterozygous for VMAT2 (VMAT2 HT). Background: Dopamine (DA) is compartmentalized by the vesicular monoamine…
  • 2017 International Congress

    Perceptions of Fluctuation Treatment in Parkinson’s Disease Impact Suicidality

    J. Hinkle, K. Perepezko, Z. Mari, L. Marsh, G. Pontone (Baltimore, MD, USA)

    Objective: Our goal was to examine the relationship between suicidality and motor fluctuations in Parkinson’s disease (PD) patients. Background: On/off motor fluctuations in PD are…
  • 2017 International Congress

    Depression, anxiety and quality of life in Multiple System Atrophy

    L. Zhang, B. Cao, Q. Wei, R. Ou, B. Zhao, J. Yang, Y. Wu, H. Shang (Chengdu, China)

    Objective: To explore the features and determinants of depression and anxiety symptoms in multiple system atrophy (MSA) and the associations between mood dysfunction and quality…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 32
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley